Table 4.
Assay and Related Substances Results for Glycopyrrolate Pre- and Postnebulization Test Samples
| Postnebulized (n = 3, mean ± SD) | ||||
|---|---|---|---|---|
| Glycopyrrolate strength | Drug assay/related substances | Prenebulized | Nebulizer 1 | Nebulizer 2 |
| 25 μg/mL | Active (% nominal concentration) | 98.70 | 98.64 ± 0.32 | 98.69 ± 0.15 |
| Known impurity 1 (%) | 0.15 | 0.15 ± 0.01 | 0.14 ± 0.00 | |
| Known impurity 2 (%) | 0.28 | 0.29 ± 0.01 | 0.28 ± 0.00 | |
| Largest unknown impurity (%) | 0.36 | 0.33 ± 0.02 | 0.34 ± 0.02 | |
| Total impurities (%) | 0.78 | 0.77 ± 0.02 | 0.76 ± 0.01 | |
| 50 μg/mL | Active (% nominal concentration) | 98.70 | 98.31 ± 0.33 | 98.76 ± 0.78 |
| Known impurity 1 (%) | <0.10 | <0.10 | <0.10 | |
| Known impurity 2 (%) | 0.23 | 0.24 ± 0.00 | 0.24 ± 0.00 | |
| Largest unknown impurity (%) | 0.14 | 0.14 ± 0.01 | 0.14 ± 0.01 | |
| Total impurities (%) | 0.38 | 0.38 ± 0.01 | 0.38 ± 0.01 | |
SD, standard deviation.